Relaxin is detectable in the mid-luteal phase of the normal menstrual cycle, and with pregnancy the levels rise rapidly and peak towards the end of the first trimester (1,2). Circulating relaxin during pregnancy is derived solely from the corpus luteum (3), and its synthesis is thought to be regulated by luteinizing hormone (LH) in both the non-pregnant (4) and preg¬ nant state (5). However, the demonstration of relaxin mRNA in the placenta suggests that relaxin synthesis may occur in this site (6), although it does not contribute to circulating levels. Relaxin infusions have several neuroendocrine effects: the circulating levels of prolactin and growth hormone are increased in primates (7); and in the rat, LH release is modulated in a steroid-dependent manner (8). In addition, relaxin has been shown to reduce and increase the circulating levels of oxytocin in the pre-and post-partum rat, respectively (9, 10). 
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In conclusion, we have demonstrated a strong positive relationship between the circulating levels of relaxin and those of E2. This suggests either that the synthesis of E2 and relaxin is regulated by a common factor or that E2, rather than LH, regulates relaxin synthesis during the menstrual cycle.
